#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dedifferentiated liposarcoma Sickle cell disease Glioblastoma Graft versus host disease Lymphatic malformation Neurofibromatosis Neurotrophic keratopathy Splenic marginal zone lymphoma Sickle cell anaemia Cortical dysplasia Hyperadrenocorticism Nephroblastoma Becker's muscular dystrophy Angiosarcoma Systemic scleroderma More trials…

    Learn about Rare Diseases

    Familial haemophagocytic lymphohistiocytosis – Diagnostics Carcinoid syndrome Pleural mesothelioma malignant – Trials in Disease Alveolar rhabdomyosarcoma – Treatment Rhabdoid tumour Kearns-Sayre syndrome – Diagnostics Propionic acidaemia – Trials in Disease Piriformis syndrome – Diagnostics Burkitt’s lymphoma Hereditary angioedema with C1 esterase inhibitor deficiency – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tafamidis Mezigdomide Vigabatrin Anakinra Piritramide Gadoxetic Acid, Disodium Benserazide Hydrochloride LTI-03 Magnesium Chloride TRAZODONE HYDROCHLORIDE Lithium Jk08 Dextromethadone Hydrochloride HRS 9531 Gemcitabine Levocetirizine Dihydrochloride BNT327 Onasemnogene Abeparvovec Ampicillin Sodium Camphor More therapies…

    Learn about Your Condition

    Breast angiosarcoma metastatic Escherichia infection Congenital pseudarthrosis Adrenoleukodystrophy Acute lymphocytic leukaemia Wolfram syndrome Infantile spasms Loeys-Dietz syndrome Inclusion body myositis Bladder cancer Pulmonary fibrosis Angiopathy Lichen sclerosus Autoimmune uveitis Metastases to liver More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

End stage renal disease

  • Study on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • End stage renal disease
    • Atrial fibrillation
    • Chronic kidney disease
    Investigated Drugs:
    • Apixaban
    Finland France Iceland The Netherlands Norway Poland +1

  • A study of canagliflozin and 18F-canagliflozin in patients with chronic kidney disease undergoing dialysis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • End stage renal disease
    Investigated Drugs:
    • Canagliflozin
    • [18F] CANAGLIFLOZIN
    The Netherlands

  • Study on the Safety of Glucothera Plus for Children with End-Stage Kidney Disease Undergoing Peritoneal Dialysis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • End stage renal disease
    Investigated Drugs:
    • Levocarnitine
    • Sodium Lactate
    • Calcium Chloride Dihydrate
    Italy

  • OM336 for Desensitization in Patients with End-Stage Renal Failure Awaiting Kidney Transplantation

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Valaciclovir
    • Buclizine Hydrochloride
    • Codeine Phosphate
    Austria

  • Study on Continuing or Stopping Immunosuppressive Therapy with Rituximab in Patients with ANCA Vasculitis and End-stage Kidney Disease

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • End stage renal disease
    • Anti-neutrophil cytoplasmic antibody positive vasculitis
    Investigated Drugs:
    • Azathioprine
    • Mycophenolate Mofetil
    • Prednisolone
    France

  • Study Comparing Rifampicin, Isoniazid, and Rifapentine Regimens for Treating Latent Tuberculosis in Patients with End-Stage Kidney Disease

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • End stage renal disease
    • Latent tuberculosis
    Investigated Drugs:
    • Pyridoxine
    • Rifapentine
    • Isoniazid
    Spain
Previous Page
1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!